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Abstract Activation of phosphodiesterase (PDE) 3B reduces
free fatty acid output from adipocytes. Induction of PDE3B gene
expression by adipocyte differentiation could improve insulin
resistance. To examine whether the PDE3B promoter is
activated by this differentiation, the 5P flanking sequence of the
mouse PDE3B gene was isolated. The transcription initiation site
was determined to be located 195 bp upstream of the translation
start site. No putative binding site for peroxisome proliferator-
activated receptor Q was found within 2 kb upstream of the
transcription initiation site. This region had promoter activity,
which was further activated on adipocyte differentiation in 3T3-
L1 cells. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Phosphodiesterase 3B (PDE3B) is a major isoform of the
PDE families in adipocytes [1]. Insulin exerts an anti-lipolytic
action via the phosphorylation and activation of PDE3B. This
activation results in a decrease in intracellular cAMP levels,
which leads to a reduction in protein kinase A activity. This
subsequently leads to the inactivation of hormone-sensitive
lipase, leading to a reduced output of free fatty acids (FFA)
from adipocytes [2^5].
Type 2 diabetes mellitus is clinically characterized by insulin
resistance in target tissues such as adipose tissue, skeletal
muscle, and liver. Reduced insulin sensitivity in adipocytes
could represent an event which occurs prior to overt insulin
resistance [6^8]. When the anti-lipolytic action of insulin is
impaired, the FFA output from adipocytes is increased. The
elevation of serum FFA causes insulin resistance in skeletal
muscle and liver as well as adipose tissues [9^11].
In prior studies, we demonstrated that basal and insulin-
induced membrane-bound PDE (mainly PDE3B) activities are
impaired in the epididymal adipocytes of insulin-resistant dia-
betic KK mice and spontaneously obese rats [12,13]. PDE3B
gene expression is also reduced in the adipocytes of obese
insulin-resistant KKAy and db/db mice and cp/cp rats
[14,15]. These ¢ndings suggest that the reduced PDE3B gene
expression in adipocytes is a general phenomenon, which is
associated with the obese insulin-resistant state.
In earlier studies, we reported that an insulin-sensitizing
drug, a derivative of thiazolidinediones, increases PDE3B
gene expression in adipose tissues of KKAy or db/db mice,
and thus improves insulin resistance [14,16]. Thiazolidine-
diones are ligands which bind to the peroxisome prolifera-
tor-activated receptor (PPAR) Q. Adipogenesis is stimulated
on PPARQ activation by ligands [17]. Thiazolidinediones in-
crease the number of small adipocytes, probably by inducing
adipocyte di¡erentiation [18,19]. PDE3B mRNA levels are
also increased in di¡erentiated 3T3-L1 adipocytes [20]. There-
fore, thiazolidinediones might induce PDE3B gene expression
via the induction of adipocyte di¡erentiation.
In view of this, we initiated an analysis of the promoter of
the mouse PDE3B gene. The 5P £anking sequence of the
mouse PDE3B gene was isolated, and an analysis of a 2-kb
portion of the 5P £anking sequence revealed the presence of
putative binding sites for some important transcription fac-
tors, but not PPARQ. This isolated region had promoter ac-
tivity and was activated on adipocyte di¡erentiation.
2. Materials and methods
2.1. Cell culture
3T3-L1 cells, purchased from Human Science Research Resources
Bank (Osaka, Japan), were grown in 10 cm dishes with low-glucose
Dulbecco’s modi¢ed Eagle’s medium (DMEM) supplemented with
10% fetal calf serum (FCS). Con£uent 3T3-L1 cells were treated
with di¡erentiation medium, namely, DMEM containing 10% FCS,
insulin (1.6 Wmol/l), dexamethasone (1.0 Wmol/l), and isobutylmethyl-
xanthine (0.5 mmol/l) for 3 days, and were then incubated with
DMEM with 10% FCS for 4^7 days until fully di¡erentiated.
2.2. RNA isolation and real-time RT-PCR
Total RNA was isolated from cell homogenates as described pre-
viously [14]. Mouse PDE3B mRNA and internal control mouse L-
actin were quantitated using the TaqMan RT-PCR method using
ABI PRISM 7700 (Perkin-Elmer Applied Biosystems, Foster City,
CA, USA). All primers and probes were designed using the Primer
Express software (Perkin-Elmer Applied Biosystems) (Table 1). The
reporter dye FAM (6-carboxy£uorescein) and VIC were used to label
the 5P terminus of PDE3B and L-actin probes, respectively. TAMRA
(6-carboxy-N,N,NP,NP-tetramethylrhodamine), which was attached at
the 3P terminus of each probe, was used as the universal quencher.
100 ng of total RNA with 1.5 Wl of 5 WM primers and 0.3 Wl of
6.8 WM PDE3B probe or 6.4 WM L-actin probe were incubated with
12.5 Wl of 2U master mix without uracil-N-glycosylase (Perkin-Elmer
Biosystems, Foster City, CA, USA), and 0.625 Wl 40U Multi Scribe
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and RNase inhibitor mix. The thermal cycle parameters described in
the protocol for the TaqMan One-Step RT-PCR Master Mix Reagent
Kit (Perkin-Elmer) were used. The comparative cycle of the threshold
method was used for quantitating mPDE mRNA following the man-
ufacturer’s protocol (Perkin-Elmer).
2.3. Primer extension
Primer extension was done as described previously [21]. Total RNA
was isolated from undi¡erentiated or di¡erentiated 3T3-L1 cells and
epididymal adipose tissue of a 10-week-old C57BL/6J mouse as de-
scribed [14]. 20 Wg of tRNA or each total RNA was used as a tem-
plate for a reverse transcriptase reaction using the mPDE0R primer
5P-end-labeled with [32P]ATP (Table 2). The M13mp18 sequence lad-
der was electrophoresed to determine the size of each cDNA product.
2.4. Isolation of the 5P £anking sequence of the mouse PDE3B gene and
DNA sequencing
A mouse genomic library constructed by EMBL-3 with a genomic
DNA isolated from the liver of an adult DBA/2J mouse (Clontech
Laboratories, Inc., Palo Alto, CA, USA) was screened with rat
PDE3B cDNA as a probe using standard hybridization methods
[22]. 15 positive clones were obtained, and one clone, which contained
exon 1, was selected by DNA sequencing. This vector was digested
with SalI, and an approximately 15-kb DNA fragment, including
exon 1, was isolated. This SalI fragment was then ligated into the
SalI site of the pBluescript KS (+) and is hereafter referred to as pSalI
PDE. The pSalI PDE contains about 5 kb of 5P £anking sequence of
the PDE3B gene. The pSalI PDE was digested with EcoRI and XbaI,
and a 5-kb fragment was isolated. This fragment was ligated into the
XbaI/EcoRI sites of pGEM7, which was named pGEM7-mPDE3B
RX. This construct was then digested with XbaI and NheI, and self-
ligated. This pGEM7-mPDE3B RN construct contained about 2.3 kb
of the mouse PDE3B 5P £anking region and the 712-bp 5P region of
exon 1.
The 5P £anking sequence was determined using the pGEM7-
mPDE3B RN as a template. The sequence was initially determined
using a reverse primer designed in exon 1 (mPDE5-R), and forward
and reverse primers were then subsequently designed based on the
determined sequence (Table 2). The DNA sequencing reaction was
performed using previously described methods [23,24].
2.5. Plasmid construction
We used the pGEM7-mPDE3B RN to prepare vectors for a lucif-
erase assay of promoter activity. A 2.1-kb of the KpnI/BamHI and a
0.4-kb of the SacI/BamHI fragments of the pGEM7-mPDE3B RN
were isolated and subcloned into the KpnI/BglII and SacI/BglII sites
of the pGL3-Basic vector (Promega, Madison, WI, USA) to obtain
pGLmPDE3B-1 and pGLmPDE3B-2, respectively. The pRL-CMV
vector, which contained renilla luciferase (Promega), was used as an
internal control for correcting transfection e⁄ciency.
2.6. Transfection and luciferase assay
The day prior to transfection, 3T3-L1 cells were plated on a 24-well
plate so as to reach a 50^90% con£uent state on the day of the trans-
fection. 1 Wg of a reporter vector, such as the pGLmPDE3B-1 or
pGLmPDE3B-2, and 5 ng of the pRL-CMV internal control vector
were diluted with 20 Wl of serum-free DMEM per well. 5 Wl of PLUS
Reagent0 (Gibco BRL, Rockville, MD, USA) was then added and
the resulting solution was incubated at room temperature (RT) for 15
min to prepare pre-complexed DNA. In a second tube, 2 Wl of Lipo-
fect AMINE Reagent0 (Gibco BRL) was mixed with 23 Wl of serum-
free DMEM per well. These pre-complexed DNAs and the diluted
Lipofect AMINE Reagent were combined and then incubated for
15 min at RT. This DNA/Lipofect AMINE Reagent mixture was
then transferred to each well, which contained 200 Wl of fresh se-
rum-free DMEM placed on 3T3-L1 cells, and then incubated at
37‡C at 5% CO2 for 3 h. The medium was exchanged to DMEM
containing 10% FCS, and the cells were incubated at 37‡C at 5%
CO2 for 24 h. The medium was exchanged to a di¡erentiation medium
when di¡erentiation was the objective, whereas it was changed to new
DMEM containing 10% FCS for undi¡erentiated controls. After 48 h
of incubation at 37‡C at 5% CO2, the medium was removed, washed
with phosphate-bu¡ered saline, and the cells were then lysed with 50
Wl of passive lysis bu¡er for 15 min. The ¢re£y luciferase activity and
renilla luciferase activity of these lysates were measured using the
Dual-Luciferase1 Reporter Assay System following the manufactur-
er’s protocol (Promega, Madison, WI, USA) and a Lumicounter 700
(MicroTech NITI-ON, Chiba, Japan).
2.7. Statistics
The Student’s t-test was used for statistical analysis unless otherwise
indicated.
3. Results
3.1. Increase in PDE3B mRNA upon adipocyte di¡erentiation
in 3T3-L1 cells
To examine whether the level of PDE3B mRNA begins to
increase during early adipocyte di¡erentiation, we employed
the TaqMan RT-PCR method (Fig. 1). The level of mPDE3B
mRNA was increased on di¡erentiation, to about two-fold at
12 h and to 3.5-fold at 24^48 h. Actinomycin D (5 Wg/ml), a
general transcription inhibitor, blocked this increase in
Table 1
Primers and probes of real-time RT-PCR
Forward primer 5P to 3P Probe 5P to 3P Reverse primer 5P to 3P
mPDE3B TGAGTGGCAGAACCAGTTTCC aCTCTGGAGCCTCATCGTTGCTGACTAATc TGCGATCCCACCTTGAACA
mL-Actin AGGTCATCACTATTGGCAACGA bATGCCCTGAGGCTCTTTTCCAGCCTTc CACAGGATTCCATACCCAAGAAG
aThe reporter dye FAM.
bThe reporter dye VIC.
cThe universal quencher TAMRA.
Table 2
Oligonucleotide for sequencing of mPDE promoter region
Primer name Forward primer 5P to 3P Reverse primer 5P to 3P Location
mPDE11-FpR TCTCAGATGA CAAGCTCGA TCGAGCTTGT CATCTGAGA 31851
mPDE12-FpR CACACAGTAA GGTTTCTCA TGAGAAACCT TACTGTGTG 31296
mPDE10-FpR CTATGTGAAA CAGTGCATG CATGCACTGT TTCACATAG 3878
mPDE9-FpR CCATCTGCCA AAGAGCTCG CGAGCTCTTT GGCAGATGG 3444
mPDE8-FpR CGGCCGTGAG GTAACTGTT AACAGTTACC TCACGGCCG 3114
mPDE4-FpR ACACCAAGAA GCCCTTCTC AGAAGGGCTT CTTGGTGTC 33
mPDE1-FpR GGAGGGCGGC GCGGGGTCGG CCGACCCCGC GCCGCCCTCC 143
mPDE0-R CTCGCGCTCG TCCTTCCTC 197
mPDE5-FpR AACGGCTACG TGAAGAGCT AGCTCTTCAC GTAGCCGTT 288
Annealing temperature is 55‡C. The standard bu¡er (TAKARA SHUZO Co., Ltd. Biomedical Group, Shiga, Japan) containing DMSO was
used. The numbers of location indicate the 5P start site (base) of each forward primer by de¢ning the transcription initiation site as +1.
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PDE3B mRNA at 24 h (data not shown). This suggests that
the increase in PDE3B mRNA by adipocyte di¡erentiation
could result, at least in part, from increased gene transcrip-
tion.
3.2. Determination of the transcription initiation site of the
mouse PDE3B gene
To determine the transcription initiation site of the mouse
PDE3B gene, primer extension was employed (Fig. 2A). When
tRNA was used as a template, no product was detected (Fig.
2A, lane 1). In contrast, only one speci¢c band was detected
with the total RNA from di¡erentiated 3T3-L1 cells or mouse
adipose tissue, but not with that from undi¡erentiated 3T3-L1
cells (Fig. 2A, lanes 2^4). Thus, the transcription initiation site
is located 195 bp upstream of the translation start site. The
sequence analysis around the transcription initiation site re-
vealed that a putative TATA or GATA box was located be-
tween 338 and 333 bp upstream of this site (Fig. 2B).
3.3. Analysis of the 5P £anking sequence of the mouse PDE3B
gene
To examine the function of the PDE3B promoter, we ¢rst
isolated the 5 kb of the 5P £anking sequence of the mouse
PDE3B gene. The sequence of about 2 kb of the promoter
region is available in EMBL (#AJ344077). Analysis by the
TFSEARCH program (http://pdap1.trc.rwcp.or.jp/research/
db/TFSEARCH.html) revealed that this region contains sev-
eral putative binding sites for some important transcription
factors, except PPARQ (Fig. 3). There are two highly con-
served regions between this mouse PDE3B promoter and hu-
man PDE3B promoter in the draft sequence. The putative
binding sites for factors such as the CCAAT/enhancer binding
protein (C/EBP) and p300 were located within the distal con-
served region. The proximal conserved region includes the
binding sites for the cAMP response element binding protein.
3.4. Basal and adipocyte di¡erentiation-induced promoter
activity of the mouse PDE3B gene in 3T3-L1 cells
To examine whether the isolated PDE3B promoter has
basal activity, we checked the two luciferase reporter con-
structs in transfection experiments, namely pGLmPDE3B-1,
which contains the region between 32075 bp and +74 bp, and
pGLmPDE3B-2, the region between 3373 and +74 bp (Fig.
4). The basal promoter activities of pGLmPDE3B-1 and
pGLmPDE3B-2 were both increased compared to those of
the pGL3-Basic vector, which has no promoter regions. This
suggests that these two regions have basal promoter activity.
To examine whether these promoter regions were further
activated on adipocyte di¡erentiation, transfected cells were
treated with the di¡erentiation medium for 48 h. The pro-
moter activities of pGLmPDE3B-1 and pGLmPDE3B-2
were induced to 1.8-fold (n = 6, P6 0.05) and 1.6-fold (n = 8,
P6 0.05), respectively. Therefore, these PDE3B promoter re-
gions appear to be further activated as the result of adipocyte
di¡erentiation.
4. Discussion
We isolated approximately 2 kb of the 5P £anking sequence
of the mouse PDE3B gene. When a search was made for
binding sites related to adipocyte di¡erentiation, C/EBP bind-
ing sites were found at 31104/31092, 31142/31136, and
31303/31290 bp. Consensus binding sites for PPAR and ster-
ol regulatory element binding protein (SREBP) were not de-
tected, although a MyoD binding site similar to E box, an-
other binding motif of SREBP, was found at 3445/3436 and
3686/3677 bp.
Fig. 1. Increase in PDE3B mRNA on adipocyte di¡erentiation in
3T3-L1 cells. Total RNA was isolated from the cells at the indicated
times after the addition of the di¡erentiation medium. The TaqMan
RT-PCR method was employed to quantitate PDE3B mRNA as de-
scribed in Section 2. The level of mouse PDE3B mRNA was nor-
malized by the level of mouse L-actin mRNA in each sample for
meaningful comparisons, and the relative amounts of PDE3B
mRNA were determined by calculating from the threshold cycles.
*P6 0.01 compared to 0 h.
Fig. 2. Determination of the transcription initiation site of the
mouse PDE3B gene. A: Primer extension was done as described in
Section 2. 20 Wg of tRNA (control) or total RNA isolated from the
indicated materials was used as a template for a reverse transcrip-
tase reaction using the mPDE0R primer 5P-end-labeled with
[32P]ATP. Transcription initiation site is located 195 bp upstream of
the translation start site as indicated by an arrow. Lanes 1: tRNA;
2: undi¡erentiated 3T3-L1 cells; 3: di¡erentiated 3T3-L1 adipo-
cytes; 4: mouse epididymal adipose tissue; M: M13mp18 sequence
ladder. B: The sequences in the vicinity of the transcription initia-
tion site are shown. A putative TATA or GATA box and the tran-
scription initiation site are indicated by arrows.
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The transcription initiation site is located 195 bp upstream
of the translation start site of the mouse PDE3B gene. The
proximal conserved region between the mouse and human
PDE3B promoter is located between 3172 bp and 330 bp,
suggesting that the basic transcription machinery may func-
tion around this conserved region. In fact, a putative TATA
or GATA box was also found between 338 and 333 bp in
this promoter.
Our ¢ndings show that PDE3B mRNA is increased at 12 h
after the induction of adipocyte di¡erentiation using sensitive
real-time RT-PCR. Previously, Taira et al. showed that fully
di¡erentiated 3T3-L1 adipocytes contain increased levels of
PDE3B mRNA compared to 3T3-L1 ¢broblasts [20]. Land-
stro«m et al. showed that PDE3B mRNA levels are increased
after 4 days of di¡erentiation [25]. These di¡erences may be
due to the sensitivity of the assays employed.
The present data show that PDE3B promoter activity, as
well as PDE3B mRNA levels, is increased on adipocyte di¡er-
entiation in vitro. This enhanced PDE3B gene expression
could improve insulin resistance through a reduced FFA out-
put from adipocytes. Thiazolidinediones improve insulin resis-
tance, probably via the induction of adipocyte di¡erentiation
in vivo [18,19]. Since the isolated PDE3B promoter lacks the
putative PPAR binding sites, this would be of particular in-
terest for a target for novel anti-diabetic drugs, which specif-
ically induce the PDE3B gene expression to reduce FFA out-
put.
In summary, we have isolated the promoter region of the
mouse PDE3B gene. The 5P £anking sequence, including the
highly conserved regions between human and mouse had pro-
moter activity, which was further activated on adipocyte dif-
ferentiation. It is not clear which DNA elements are respon-
sible for the basal and di¡erentiation-induced promoter
activity, and which transcription factors bind these elements.
Further experiments will be needed to clarify these points.
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